Skip to content
10-K

Annual Report

AVENUE THERAPEUTICS, INC. ATXI

0001437749-26-010359

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 25, 2026 3.29M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$1.83M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$9.03M
Cash And Equivalents FY 2025 · Dec 31, 2025 $2.86M
Cash And Equivalents FY 2025 · Dec 31, 2024 $2.59M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.83M
Stockholders Equity FY 2025 · Dec 31, 2024 $2.8M
Current Liabilities FY 2025 · Dec 31, 2025 $1.1M
Current Liabilities FY 2025 · Dec 31, 2024 $816K
Total Liabilities FY 2025 · Dec 31, 2025 $1.1M
Total Liabilities FY 2025 · Dec 31, 2024 $816K
Total Assets FY 2025 · Dec 31, 2025 $2.93M
Total Assets FY 2025 · Dec 31, 2024 $2.67M
Eps Basic FY 2025 · Dec 31, 2025 −$0.93
Eps Basic FY 2025 · Dec 31, 2024 −$15.79
Sga Expense FY 2025 · Dec 31, 2025 $3.65M
Sga Expense FY 2025 · Dec 31, 2024 $4.64M
Rd Expense FY 2025 · Dec 31, 2025 $1.04M
Rd Expense FY 2025 · Dec 31, 2024 $6.65M
Net Income FY 2025 · Dec 31, 2025 −$2.91M
Net Income FY 2025 · Dec 31, 2024 −$11.65M
Operating Income FY 2025 · Dec 31, 2025 −$3.08M
Operating Income FY 2025 · Dec 31, 2024 −$11.28M
Revenue FY 2025 · Dec 31, 2025 $1.4M
Revenue FY 2025 · Dec 31, 2024 $0